Interaction of urinary crystals with renal epithelial cells in the pathogenesis of nephrolithiasis

Seminars in Nephrology

Volumn 16, Issue 5, 1996, Pages 458-473

  Lieske, John C ^a,b   Toback, F Gary ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Section of Nephrology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION; CELL PROLIFERATION; CRYSTALLIZATION; GENE EXPRESSION; HUMAN; INTERNALIZATION; KIDNEY EPITHELIUM; NEPHROLITHIASIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

CALCIUM OXALATE; CELLS, CULTURED; EPITHELIAL CELLS; EPITHELIUM; HUMANS; KIDNEY; KIDNEY CALCULI; KIDNEY TUBULES, DISTAL;

EID: 0029758743     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Finlayson B, Reid S: The expectation of free and fixed particles in urinary stone disease. Invest Urol 15:442-448, 1978
2. Lieske JC, Toback FG: Regulation of renal epithelial cell endocytosis of calcium oxalate monohydrate crystals. Am J Physiol 264:F800-F807, 1993
3. Lieske JC, Walsh-Reitz MM, Toback FG: Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol 262:F622-F630, 1992
4. Lieske JC, Leonard R, Toback FG: Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 268:F604-F612, 1995
5. Lieske JC, Leonard R, Swift HS, et al: Adhesion of calcium oxalate monohydrate crystals to anionic sites on the surface of renal epithelial cells. Am J Physiol 270:F192-F199, 1996
6. Randall A: The origin and growth of renal calculi. Ann Surg 105:1009-1020, 1937
7. . 7. Lieske JC, Spargo B, Toback FG: Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria. J Urol 148:1517-1519, 1992
8. Saxon A, Busch GJ, Merrill JP, et al: Renal transplantation in primary hyperoxaluria. Arch Intern Med 133:464-467, 1974
9. Mandell I, Krauss E, Millan JC: Oxalate-induced acute renal failure in Crohn's Disease. Am J Med 69:628-632,1980
10. Wharton R, D'Agati V, Magun AM, et al: Acute deterioration of renal function associated with enteric hyperoxaluria. Clin Nephrol 34:116-121, 1990
11. Gelbart DR, Brewer LL, Fajardo LF, et al: Oxalosis and chronic renal failure after intestinal bypass. Arch Intern Med 137:239-243, 1977
12. Kok DJ, Khan SR: Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847-854, 1994
13. Schulz E, Schneider H-J: A new view of stone formation under the aspect of flow dynamics, in Smith LH, Robertson WG, Finlayson B (eds): Urolithiasis, Clinical and Basic Research. New York: Plenum, 1981, p 533-537
14. Lieske JC, Swift HS, Martin T, et al: Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals. Proc Natl Acad Sci USA 91:6987-6991, 1994
15. Khan SR, Finlayson B, Hackett RL: Experimental calcium oxalate nephrolithiasis in the rat. Am J Pathol 107:5969, 1982
16. Hammes MS, Lieske JC, Pawar S, et al: Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kidney Int 48:501-509, 1995
17. Angell AH, Resnick MI: Surface interaction between glycosaminoglycans and calcium oxalate. J Urol 141:1255-1258, 1989
18. Shum DKY, Gohel MDI: Separate effect of urinary chondroitin sulfate and heparan sulfate on the crystallization of urinary calcium oxalate: Differences between stone formers and normal control subjects. Clin Sei 85:33-39, 1993
19. Verkoelen CF, Romijn JC, Cao LC, et al: Crystal-cell interaction inhibition by polysaccharides. J Urol 155:749-752, 1996
20. Parks JH, Coe FL: Urine citrate and calcium in calcium nephrolithiasis. Adv Exp Med Biol 208:445-449, 1986
21. Ito H, Coe FL: Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine. Am J Physiol 233:F455-F463, 1977
22. Martin X, Wemess PG, Bergert JH, et al: Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth. J Urol 132:786-788, 1984
23. Subha K, Baskar R, Varalakshmi P: Biochemical changes in kidneys of normal and stone forming rats with sodium pentosan polysulphate. Biochem Int 26:357-365, 1992
24. Mandel NS, Mandel GS, Hasegawa AT: The effect of some urinary stone inhibitors on membrane interaction potentials of stone crystals. J Urol 138:557-562, 1987
25. Worcester EM, Nakagawa Y, Wabner CL, et al: Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. Am J Physiol 255:F1197-F1205, 1988
26. Shiraga H, Min W, VanDusen WJ, et al: Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sei USA 89:426-430, 1992
27. Hess B, Nakagawa Y, Coe FL: Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257:F99-106, 1989
28. Nakagawa Y, Abram V, Kezdy FJ, et al: Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem 258:12594-12600, 1983
29. Kumar S, Muchmore A: Tamm-Horsfall protein-uromodulin (1950-1990): Editorial Review. Kidney Int 37:1395-1401, 1990
30. Gohel MD, Shum DKY, Li MK: The dual effect of urinary macromolecules on the crystallization of calcium oxalate endogenous in urine. Urol Res 20:13-17, 1992
31. Drach GW, Randolph AD, Miller JD: Inhibition of calcium oxalate dihydrate crystallization by chemical modifiers: I. Pyrophosphate and methylene blue. J Urol 119:99-103, 1978
32. Riet BV, O'Rear CE, Smith MJV: Methylene blue and other agents as inhibitors of calcium oxalalithiasis in vivo. Invest Urol 16:201-203, 1978
33. Smith MJV: Methylene blue in renal calculi. Urol 6:676-679, 1975
34. Lloyd SE, Pearce SHS, Fisher SE, et al: A common molecular basis for three inherited kidney stone diseases. Nature 379:445-449, 1996
35. Riese RJ, Riese JW, Kleinman JG, et al: Specificity in calcium oxalate adherence to papillary epithelial cells in culture. Am J Physiol 255:F1025-F1032, 1988
36. Riese RJ, Mandel NS, Wiessner JH, et al: Cell polarity and calcium oxalate crystal adherence to cultured collecting duct cells. Am J Physiol 262:F177-F184, 1992
37. Khan SR, Cockrell CA, Finlayson B, et al: Crystal retention by injured urothelium of the rat urinary bladder. J Urol 132:153-157, 1984
38. Mandel N: Crystal-membrane interaction in kidney stone disease. J Am Soc Nephrol 5:S37-S45, 1994
39. Holley RW, Armour R, Baldwin JH: Density-dependent regulation of growth of BSC-1 cells in cell-culture: Control of growth by low molecular weight nutrients. Proc Natl Acad Sei USA 75:339-341, 1978
40. Kartha S, Toback FG: Purine nucleotides stimulate DNA synthesis in kidney epithelial cells in culture. Am J Physiol 249:F967-F972, 1987
41. Walsh-Reitz MM, Toback FG: Kidney epithelial cell growth is stimulated by lowering extracellular potassium concentration. Am J Physiol 244:C429-C432, 1983
42. Kartha S, Toback FG: Adenine nucleotides stimulate migration in wounded cultures of kidney epithelial cells. J Clin Invest 90:288-292, 1992
43. Kartha S, Atkin B, Martin TE, et al: Cytokeratin reorganization induced by adenosine diphosphate in kidney epithelial cells. Exp Cell Res 200:219-226, 1992
44. Waack S, Walsh-Reitz MM, Toback FG: Extracellular potassium modifies the structure of kidney epithelial cells in culture. Am J Physiol 249:C105-C110, 1985
45. Ruoslahti E, Yamaguchi Y: Proteoglycans as modulators of growth factor activities. Cell 64:867-869, 1991
46. Williams SP, Mason RM: Modulation of proteoglycan synthesis by bovine vascular smooth muscle cells during cellular proliferation and treatment with heparin. Arch Biochem Biophys 287:386-396, 1991
47. Pukac LA, Otilinger ME, Kamovsky MJ: Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J Biol Chem 267:3707-3711, 1992
48. Dasso LLT, Taylor CW: Heparin and other polyanions uncouple alpha-adrenoreceptors from G proteins. Biochem J 280:791-795, 1991
49. Elingsworth LR, Brennan JE, Fok K, et al: Antibodies to the N-terminal portion of cartilage-inducing factor-A and transforming growth factor beta. J Biol Chem 261:12362-12367, 1986
50. Thompson NL, Flanders KC, Smith JM, et al: Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice. J Cell Biol 108:661-669, 1989
51. Hess B: Tamm-Horsfall glycoprotein: Inhibitor or promoter of calcium oxalate monohydrate crystallization processes? Urol Res 20:83-86, 1992
52. Sherblom AP, Sathyamoorthy N, Decker JM," et al: IL-1, a lectin with high specificity for high mannose glycopeptides. J Immunol 143:939-944, 1989
53. Sherblom AP, Decker JM, Muchmore AV: The lectinlike interaction between recombinant tumor necrosis factor and uromodulin. J Biol Chem 263:5418-5424, 1988
54. Axline SG, Reaven EP: Inhibition of phagocytosis and plasma membrane mobility of the cultivated macrophage by cytochalasin B: Role of subplasmalemmal microfilaments. J Cell Biol 62:647-659, 1974
55. Cheung HS, Story MT, McCarty DJ: Mitogenic effects of hydroxyapatite and calcium pyrophosphate dihydrate crystals on cultured mammalian cells. Arthritis Rheum 27:668-674, 1984
56. Hackett RL, Shevock PN, Khan SR: Madin-Darby canine kidney cells are injured by exposure to oxalate and calcium oxalate crystals. Urol Res 22:197-204, 1994
57. Verkoelen CF, Romijn JC, DeBruijn C, et al: Association of calcium oxalate monohydrate crystals with MDCK cells. Kidney Int 48:129-138, 1995
58. Khan SR: Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 23:71-79, 1995
59. Koul H, Kennington L, Nair G, et al: Oxalate-induced initiation of DNA synthesis in LLC-PK1 cells, a line of renal epithelial cells. Biochem Biophys Res Commun 205:1632-1637, 1994
60. Brett F, Kealy WF, Murnaghan D, et al: Primary hyperoxaluria - a case report. Ir J Med Sei 159:78-79, 1990
61. Canos HJ, Hogg GA, Jeffery JR: Oxalate nephropathy due to gastrointestinal disorders. Can Med Assoc J 124:729-733, 1981
62. Das S, Joseph B, Dick AL: Renal failure owing to oxalate nephrosis after jejunoileal bypass forobsesity. J Urol 121:506-509, 1979
63. Koten JW, Van Gastel C, Dorhout Mees EJ, et al: Two cases of primary oxalosis. J Clin Pathol 18:223-229, 1965
64. Salyer WR, Keren D: Oxalosis as a complication of chronic renal failure. Kidney Int 4:61-66, 1973
65. Fransino JA, Vanamee P, Rosen PP: Renal oxalosis and azotemia after methoxyflurane anesthesia. N Engl J Med 283:676-679, 1970
66. Dezengher FE, Wolff ED, Heijn AJ, et al: Oxalosis in infancy. Clin Nephrol 22:114-120, 1984
67. Ehlers SM, Posalaky Z, Strate RG, et al: Acute reversible renal failure following jejunoileal bypass for morbid obesity: A clinical and pathological (EM) study of a case. Surgery 82:629-634, 1977
68. Drenick EJ, Stanley TM, Border WA, et al: Renal damage with intestinal bypass. Ann Intern Med 89:594-599, 1978
69. Bradham DM, Igarashi A, Potter RL, et al: Connective tissue growth factor: A cysteine rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114:1285-1294, 1993
70. Terisma T, Tolmach LJ: Growth and nucleic acid synthesis in synchronously dividing populations of HeLa cells. Exp Cell Res 30:344-362, 1963
71. Khan SR, Hackett RL: Retention of calcium oxalate crystals in renal tubules. Scanning Microsc 5:707-712, 1991
72. Werb Z, Tremble PM, Behrendtsen O, et al: Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 109:877-889, 1980
73. Khan SR, Shevock PN, Hackett RL: Membrane associated crystallization of calcium oxalate in vitro. Calcif Tissue Int 46:116-120, 1990